Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammatory Bowel Diseases × Oxygen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Lung Neoplasms 3 Anxiety Disorders 3 Solitary Pulmonary Nodule 2 Paresthesia 2 Multiple Pulmonary Nodules 2 Hypesthesia 2 Dyspnea 2 Depression 2 Brain Neoplasms 2 Surgical Wound Infection 1 Skin Neoplasms 1 Radiation Injuries 1 Pulmonary Atelectasis 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Prostatic Diseases 1 Postoperative Complications 1 Pain 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia 1 Laparotomy 1 Inflammatory Bowel Diseases 1 Hypoxia 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Infliximab 5 Tea 3 Polyethylene Glycols 3 Blood Specimen Collection 3 Standard of Care 2 MEDI2070 2 Lidocaine 2 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2 Colonoscopy 2 CT-P13 2 Biopsy 2 Adalimumab 2 sodium phosphate 1 purine 1 prucalopride 1 polyethylene glycol 400 1 picosulfate sodium 1 golimumab 1 fumaric acid 1 cabozantinib 1 Tumor Necrosis Factor Inhibitors 1 Thrombin Time 1 Surveys and Questionnaires 1 Surgical Tape 1 Sulfasalazine 1 Spectrum Analysis, Raman 1 Specimen Handling 1 Single-Balloon Enteroscopy 1 Registries 1 Proctocolectomy, Restorative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06109961 2023-11-07

HYPNOTIC

Ottawa Hospital Research Institute

Phase 1/2 Unknown

Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡